Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRS-1301 and Rosuvastatin PK Study
NCT07097831Phase 1Completed
- Sponsor
- Shandong Suncadia Medicine Co., Ltd.
- Start
- Oct 2025
- Primary completion
- Nov 2025
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of HRS-1301 in hyperlipidemia, sponsored by Shandong Suncadia Medicine Co., Ltd. Primary endpoints: Area under the curve from time 0 to time t, Area under the curve from time 0 to time infinity and 1 more. Started Oct 2025; status: completed.
02
Drugs
HRS-1301
03
Conditions
hyperlipidemia
Beyond the preview
Go deeper on NCT07097831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07097831.